Reporting owner
Forbes William P
Reporting owner CIK 0001314760 · EVP, Chief Development Officer
These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
8 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 19, 2026 | HERON THERAPEUTICS, INC. /DE/Common Stock | Forbes William P | Exercise / conversion |
| Nov 4, 2025 | Beyond Air, Inc.Stock Options (Right to buy) | Forbes William P | Stock award |
| Nov 4, 2025 | Beyond Air, Inc.Stock Options (Right to buy) | Forbes William P | Stock award |
| Nov 4, 2025 | Beyond Air, Inc.Stock Options (Right to buy) | Forbes William P | Stock award |
| Nov 4, 2025 | Beyond Air, Inc.Stock Options (Right to buy) | Forbes William P | Stock award |
| Nov 4, 2025 | Beyond Air, Inc.Stock Options (Right to buy) | Forbes William P | Stock award |
| Oct 31, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Forbes William P | Exercise / conversion |
| Oct 19, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Forbes William P | Exercise / conversion |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transactions in associated filings
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | HERON THERAPEUTICS, INC. /DE/HRTX · company listings | Forbes William PEVP, Chief Development Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,874 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Beyond Air, Inc.XAIR · company listings | Forbes William PDirector | Stock awardStock Options (Right to buy)Derivative security · Code A | 3,750 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Beyond Air, Inc.XAIR · company listings | Forbes William PDirector | Stock awardStock Options (Right to buy)Derivative security · Code A | 2,250 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Beyond Air, Inc.XAIR · company listings | Forbes William PDirector | Stock awardStock Options (Right to buy)Derivative security · Code A | 2,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Beyond Air, Inc.XAIR · company listings | Forbes William PDirector | Stock awardStock Options (Right to buy)Derivative security · Code A | 1,500 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Beyond Air, Inc.XAIR · company listings | Forbes William PDirector | Stock awardStock Options (Right to buy)Derivative security · Code A | 400 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | HERON THERAPEUTICS, INC. /DE/HRTX · company listings | Forbes William PEVP, Chief Development Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 11,694 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | HERON THERAPEUTICS, INC. /DE/HRTX · company listings | Forbes William PEVP, Chief Development Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,874 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
8 transactions on this page. Filing date, newest first.